PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Mark Kay to Give Keynote Presentation at RNAi Conference on June 20-21 in San Francisco, California - Mark Kay, Professor of Pediatrics and Genetics at Stanford University, will give a keynote presentation on microRNAs at the 4th RNAi Research & Therapeutics Conference on June 20-21, 2013 in San Francisco, CA - GTCbio.com
Mark Kay to Give Keynote Presentation at RNAi Conference on June 20-21 in San Francisco, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/03/26 - Mark Kay, Professor of Pediatrics and Genetics at Stanford University, will give a keynote presentation on microRNAs at the 4th RNAi Research & Therapeutics Conference on June 20-21, 2013 in San Francisco, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Recent studies suggest that there is a great deal of variation in the way that different long primary miRNA (pri-miRNA) and precursor miRNAs (pre-miRNAs) are processed in cells. As a result, there is a great deal of heterogeneity in the generation of the final population of bio-active miRNA molecules. Variation in miRNA processing likely influences the degree to which specific gene regulatory pathways are regulated.

Professor Kay will discuss how investigating the mechanisms by which these miRNAs are made have aided him and his lab in designing improved vector-based transcriptional RNAi approaches that result in higher levels of efficacy and fewer off-targeting effects. He will describe how these new designs and approaches to deliver them into humans to treat serious diseases, as well as discuss how miRNAs that are generated or function through non-canonical processes hold important insights into additional approaches that might be used for disease intervention.

Mark A. Kay, MD, PhD, is the Dennis Farrey Family Professor in the Departments of Pediatrics and Genetics, Human Gene Therapy Division Head, and Vice Chair for Basic Research in Pediatrics at Stanford University’s School of Medicine. His work has led to the discovery and development of minicircle DNA vectors for genetic modification of cells in vitro and in vivo, and his laboratory was the first to demonstrate functional RNAi in whole mammals including their ability to inhibit human viral replication in vivo. Dr. Kay is one of the founders of the American Society of Gene Therapy and served as the President in 2005-2006, and currently serves on the board of directors of the Oligonucleotide Therapeutic Society. In 2013, he received the Outstanding Investigator Award from the American Society of Gene and Cell Therapy.

GTC’s 4th RNAi Research & Therapeutics Conference will provide a forum for leaders from academia and industry to share their perspective and progress in RNA delivery and validation applications and network with fellow scientists and principle investigators to discuss the future of RNA-related discovery.

The conference is part of the Nucleic Acid Summit 2013, which includes two other exciting meetings:

- Bioinformatics & Data Management Strategies Workshop
- 3rd Next-Generation Sequencing Conference

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Mark Kay to Give Keynote Presentation at RNAi Conference on June 20-21 in San Francisco, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)